In most cases of GBM, there are mutations in the p53 protein pathway and in the RB1 gene of the retinoblastoma protein Rb with 87% and 78% of patients, respectively, according to data from The Cancer Genome Atlas Program (TCGA). Here, RB1 is linked to glioblastoma.